Inventor · disambiguated record
Dingjiang Liu
Also filed as: LIU DINGJIANG
15 granted patents·10 pending applications·20 citations·filing 2001–2025
89Inventor score
Top patents by PatentIndex Score
25 records- 0185US12337199B2Stable antibody formulationREGENERON PHARMA·Filed 2021·Granted Jun 24, 2025·1 cites·63 claims
- 0285US11603407B2Stable antibody formulationREGENERON PHARMA·Filed 2018·Granted Mar 14, 2023·4 cites·24 claims
- 0384US11850535B2Methods for quantitating individual antibodies from a mixtureREGENERON PHARMA·Filed 2022·Granted Dec 26, 2023·0 cites·20 claims
- 0484US2023415073A1Methods for quantitating individual antibodies from a mixtureREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0579US10072085B2Method of treating psoriasis using an IL-17 receptor antibody formulationKIRIN AMGEN INC·Filed 2014·Granted Sep 11, 2018·4 cites·5 claims
- 0676US11571636B2Methods for quantitating individual antibodies from a mixtureREGENERON PHARMA·Filed 2021·Granted Feb 7, 2023·0 cites·22 claims
- 0776US8883151B2IL-17 receptor antibody formulationLIU DINGJIANG·Filed 2011·Granted Nov 11, 2014·6 cites·6 claims
- 0875US2023192873A1Method of treating diseases using an il-17 receptor antibody formulationAMGEN K A INC·Filed 2022·Application pending·0 cites
- 0974US11369896B2Methods for quantitating individual antibodies from a mixtureREGENERON PHARMA·Filed 2020·Granted Jun 28, 2022·0 cites·23 claims
- 1073US9283260B2Lyophilized therapeutic peptibody formulationsCALLAHAN WILLIAM J·Filed 2007·Granted Mar 15, 2016·5 cites·8 claims
- 1169US11505612B2Method of treating diseases using an IL-17 receptor antibody formulationAMGEN K A INC·Filed 2020·Granted Nov 22, 2022·0 cites·6 claims
- 1269US2025306029A1Characterization of adeno-associated virus using microchip capillary electrophoresisREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1368US10808033B2IL-17 receptor antibody formulationAMGEN K A INC·Filed 2018·Granted Oct 20, 2020·0 cites·6 claims
- 1467US12320814B2Characterization of adeno-associated virus using microchip capillary electrophoresisREGENERON PHARMA·Filed 2021·Granted Jun 3, 2025·0 cites·9 claims
- 1567US2025288665A1Stable antibody formulationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1665US11020686B2Methods for quantitating individual antibodies from a mixtureREGENERON PHARMA·Filed 2017·Granted Jun 1, 2021·0 cites·22 claims
- 1765US2023183348A1Stable antibody formulationREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1862US2025101387A1Methods for analyzing dna using enhanced performance chromatography systemsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1961US2024209415A1Droplet digital pcr assay for determining viral vector genomic titerREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2057US11596690B2Stabilized formulations containing anti-IL-33 antibodiesREGENERON PHARMA·Filed 2020·Granted Mar 7, 2023·0 cites·29 claims
- 2157US2021054050A1Formulation optimization for bispecific antibodiesREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 2256US2023293724A1Lyophilized Formulations of AAV Drug ProductsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2347US7459296B2Hepatitis C virus NS3 helicase subdomain ISCHERING CORP·Filed 2001·Granted Dec 2, 2008·0 cites·7 claims
- 2445US10166189B2Lyophilized therapeutic peptibody formulationsAMGEN INC·Filed 2016·Granted Jan 1, 2019·0 cites·6 claims
- 2536US2013171128A1Reducing viscosity of pharmaceutical formulationsHUANG HOLLY ZHUOHONG·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dingjiang Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →